SM
KYNB

Sabby Management’s Kyntra Bio KYNB Stock Holding History

Sabby Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13
Closed -$1.83M – 95
2019
Q1 		$1.83M Buy
+13
New +$17.6K 0.88% 16
2018
Q4 		– Sell
-37
Closed -$5.57M – 129
2018
Q3 		$5.57M Buy
+37
New +$57K 0.71% 24
2018
Q2 		– Sell
-5
Closed -$522K – 156
2018
Q1 		$522K Sell
5
-6
-55% -$7.9K 0.06% 95
2017
Q4 		$1.3M Sell
11
-44
-80% -$55.2K 0.12% 62
2017
Q3 		$7.45M Sell
55
-6
-10% -$6.32K 0.49% 27
2017
Q2 		$4.96M Buy
61
+23
+61% +$16K 0.32% 40
2017
Q1 		$2.32M Sell
38
-10
-21% -$6.09K 0.13% 80
2016
Q4 		$2.54M Buy
48
+41
+586% +$20.5K 0.15% 87
2016
Q3 		$339K Buy
+7
New +$3.3K 0.01% 248

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Sabby Management's KYNB Position: Q4 2020 in Review

Sabby Management sold out of Kyntra Bio (KYNB) in Q4 2020, closing a stake of 1,186 shares — an estimated $1.22M sold.

Sabby Management first reported a position in KYNB in Q1 2015 and held it in 12 quarters. The position peaked at $2.32M in Q1 2016. 207 funds tracked by Wall St. Rank hold KYNB as of Q4 2020.

  • Sabby Management reported no remaining Kyntra Bio position as of Q4 2020 after selling out during the quarter.
  • Sabby Management sold 1,186 Kyntra Bio shares in Q4 2020, an estimated $1.22M.
  • Sabby Management first reported a position in Kyntra Bio in Q1 2015 and held it in 12 quarters.
  • Sabby Management's Kyntra Bio position peaked at $2.32M in Q1 2016.
  • 207 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.